Advertisement

The Indian Journal of Pediatrics

, Volume 85, Issue 6, pp 411–412 | Cite as

Biomarkers for Diagnosing Ventilator Associated Pneumonia: Is that the Way Forward?

  • Arvind Kumar
  • Rakesh Lodha
Editorial Commentary
  • 115 Downloads

Ventilator associated pneumonia (VAP) is an important life-threatening complication in Intensive care unit (ICU) setting [1]. It is associated with longer duration of mechanical ventilation, hospital stay, increased treatment cost, and also attributable mortality. VAP is suspected using clinical criteria supported by investigations such as leukocyte counts and chest radiograph. Diagnosis of VAP in critically ill children is more difficult with non-specific clinical and radiological findings in presence of many concurrent cardiopulmonary factors (atelectasis, pulmonary hemorrhage, congestive heart failure, underlying pneumonia, etc.).

For microbiologic confirmation, bronchoalveolar lavage is the most feasible sample which can be obtained by bronchoscopy or by a blind non-bronchoscopic technique. The culture results take approximately 48–72 h. There is also a need to differentiate actual infection from bacterial colonization of lower airways that develops rapidly with endotracheal tube [

Notes

Compliance with Ethical Standards

Conflict of Interest

None.

References

  1. 1.
    CDC: Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU] Event). pg1–16. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/6pscVAPcurrent.pdf. Accessed 26 Feb 2018.
  2. 2.
    Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867–903.CrossRefPubMedGoogle Scholar
  3. 3.
    Luyt CE, Combes A, Reynaud C, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med. 2008;34:1434–40.CrossRefPubMedGoogle Scholar
  4. 4.
    Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem. 2008;45:293–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Conway Morris A, Kefala K, Wilkinson TS, et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax. 2010;65:201–7.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350:451–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Anand NJ, Zuick S, Klesney-Tait J, Kollef MH. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest. 2009;135:641–7.Google Scholar
  8. 8.
    Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care. 2008;12:R11.Google Scholar
  9. 9.
    Srinivasan R, Song Y, Wiener-Kronish J, Flori HR. Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients. Pediatr Crit Care Med. 2011;12:21–7.Google Scholar
  10. 10.
    Determann RM, Millo JL, Waddy S, Lutter R, Garrard CS, Schultz MJ. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study. BMC Pulm Med. 2009;9:49.Google Scholar
  11. 11.
    Flanagan PG, Jackson SK, Findlay G. Diagnosis of gram negative, ventilator associated pneumonia by assaying endotoxin in bronchial lavage fluid. J Clin Pathol. 2001;54:107–10.Google Scholar
  12. 12.
    Tekerek NU, Akyildiz BN, Ercal BD, Muhtaroglu S. New biomarkers to diagnose ventilator associated pneumonia: pentraxin 3 and surfactant protein D. Indian J Pediatr. 2018.  https://doi.org/10.1007/s12098-018-2607-2.
  13. 13.
    Afify MH, Shaheen EA, El-Dahdouh SS, El-Feky HM. Comparison between bronchoscopic BAL and non-bronchoscopic BAL in patients with VAP. Egyptian J Chest Dis Tubercul. 2016;65:113–9.CrossRefGoogle Scholar
  14. 14.
    Said AS, Abd-Elaziz MM, Farid MM, et al. Evolution of surfactant protein-D levels in children with ventilator-associated pneumonia. Pediatr Pulmonol. 2012;47:292–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Srinivasan R, Song Y, Wiener-Kronish J, Flori H. A pilot study of biological markers of host defense in pediatric ventilator−associated pneumonia [VAP]. Am J Respir Crit Care Med. 2009;179:A2588.Google Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  1. 1.Department of PediatricsAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations